100.39
price down icon0.31%   -0.31
after-market Dopo l'orario di chiusura: 100.39
loading
Precedente Chiudi:
$100.70
Aprire:
$100.65
Volume 24 ore:
613.15K
Relative Volume:
0.48
Capitalizzazione di mercato:
$6.56B
Reddito:
$1.54B
Utile/perdita netta:
$233.56M
Rapporto P/E:
29.82
EPS:
3.3669
Flusso di cassa netto:
$348.64M
1 W Prestazione:
-0.58%
1M Prestazione:
-0.58%
6M Prestazione:
+20.63%
1 anno Prestazione:
+91.22%
Intervallo 1D:
Value
$100.37
$100.98
Intervallo di 1 settimana:
Value
$100.37
$101.02
Portata 52W:
Value
$49.67
$111.86

Lantheus Holdings Inc Stock (LNTH) Company Profile

Name
Nome
Lantheus Holdings Inc
Name
Telefono
978 671-8001
Name
Indirizzo
331 TREBLE COVE ROAD, NORTH BILLERICA, MA
Name
Dipendente
1,193
Name
Cinguettio
Name
Prossima data di guadagno
2026-08-06
Name
Ultimi documenti SEC
Name
LNTH's Discussions on Twitter

Compare LNTH vs TAK, TEVA, HLN, ZTS, UTHR

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
LNTH icon
LNTH
Lantheus Holdings Inc
100.39 6.58B 1.54B 233.56M 348.64M 3.3669
TAK icon
TAK
Takeda Pharmaceutical Co Adr
18.11 58.15B 29.91B 1.30B 3.49B 0.4056
TEVA icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
36.35 42.94B 17.53B 1.58B 444.18M 1.3457
HLN icon
HLN
Haleon Plc Adr
9.22 40.59B 14.54B 2.22B 2.58B 0.4871
ZTS icon
ZTS
Zoetis Inc
72.86 30.29B 9.51B 2.64B 2.14B 6.0361
UTHR icon
UTHR
United Therapeutics Corp
503.86 21.74B 3.17B 1.29B 1.01B 27.09

Lantheus Holdings Inc Stock (LNTH) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2026-02-26 Aggiornamento William Blair Mkt Perform → Outperform
2025-12-12 Aggiornamento Truist Hold → Buy
2025-10-08 Downgrade Goldman Buy → Neutral
2025-08-12 Downgrade Truist Buy → Hold
2024-12-18 Iniziato Goldman Buy
2024-09-03 Iniziato Redburn Atlantic Buy
2024-07-10 Reiterato JMP Securities Mkt Outperform
2023-12-18 Downgrade William Blair Outperform → Mkt Perform
2023-12-04 Iniziato TD Cowen Outperform
2023-09-29 Iniziato William Blair Outperform
2023-03-08 Iniziato JMP Securities Mkt Outperform
2022-11-30 Iniziato SVB Leerink Outperform
2022-10-13 Iniziato Mizuho Buy
2022-05-09 Iniziato B. Riley Securities Buy
2022-04-13 Iniziato Truist Buy
2021-02-01 Iniziato SVB Leerink Outperform
2020-06-29 Ripresa Jefferies Buy
2019-08-16 Aggiornamento CJS Securities Market Perform → Market Outperform
2017-11-02 Aggiornamento Wells Fargo Market Perform → Outperform
2016-11-08 Reiterato RBC Capital Mkts Outperform
2016-09-23 Ripresa Credit Suisse Neutral
2016-02-24 Reiterato RBC Capital Mkts Outperform
2015-12-11 Downgrade Credit Suisse Outperform → Neutral
2015-09-30 Downgrade Wells Fargo Outperform → Market Perform
2015-07-20 Iniziato Credit Suisse Outperform
2015-07-20 Iniziato Jefferies Buy
2015-07-20 Iniziato RBC Capital Mkts Outperform
2015-07-20 Iniziato Robert W. Baird Outperform
2015-07-20 Iniziato Wells Fargo Outperform
Mostra tutto

Lantheus Holdings Inc Borsa (LNTH) Ultime notizie

pulisher
04:18 AM

Lantheus Holdings Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Lantheus Holdings, Inc.LNTH - Business Wire

04:18 AM
pulisher
Sep 09, 2026

LNTH Stock Drops After-Hours As Curium's $7B Offer Comes In Below Market Value - Stocktwits

Sep 09, 2026
pulisher
Sep 08, 2026

Perspective Therapeutics (CATX) Insider Sale: 10% Owner Lantheus Alpha Therapy, LLC Sells 247,932 Shares - GuruFocus

Sep 08, 2026
pulisher
Sep 08, 2026

Perspective Therapeutics (CATX) holder sells stock near $3.10 - Stock Titan

Sep 08, 2026
pulisher
Sep 08, 2026

Lantheus Alpha Therapy Sells 113,914 Perspective Therapeutics (AMEX: CATX) Shares at Up to $3.14 Per Share - Kalkine Media

Sep 08, 2026
pulisher
Sep 08, 2026

Lantheus Entities Hold 20.9% Stake in Radiopharm Theranostics (NASDAQ: RADX) Including Significant Options - Kalkine Media

Sep 08, 2026
pulisher
Sep 08, 2026

Lantheus Group Reduces Stake in Perspective Therapeutics (AMEX: CATX) to 10% Amid Activist 13D Filing - Kalkine Media

Sep 08, 2026
pulisher
Sep 08, 2026

Lantheus Holdings (NASDAQ: LNTH) 10% Stakeholder Alpha Therapy Sells 42,129 Shares at $3.11 Each - Kalkine Media

Sep 08, 2026
pulisher
Sep 08, 2026

Lantheus (NASDAQ: LNTH) holders to vote on cash buyout with potential bonus payout - Stock Titan

Sep 08, 2026
pulisher
Sep 07, 2026

Radioligand Therapy Market to Grow from USD 2.98 Billion in 2025 to USD 15.85 Billion by 2035, at a CAGR of 18.2% - GlobeNewswire Inc.

Sep 07, 2026
pulisher
Sep 07, 2026

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring Growth Potential in the Healthcare Sector - DirectorsTalk Interviews

Sep 07, 2026
pulisher
Sep 05, 2026

Lantheus alpha therapy, CATX director, sells $131k in stock By Investing.com - Investing.com Australia

Sep 05, 2026
pulisher
Sep 05, 2026

Lantheus alpha therapy, CATX director, sells $131k in stock - Investing.com

Sep 05, 2026
pulisher
Sep 05, 2026

Perspective Therapeutics (CATX) Insider Sell: 10% Owner Lantheus Alpha Therapy, LLC Disposes of 42,129 Shares - GuruFocus

Sep 05, 2026
pulisher
Sep 04, 2026

Lantheus Holdings (NASDAQ: LNTH) Disposes of 35,769 Perspective Therapeutics Shares at $3.12 Each - kalkinemedia.com

Sep 04, 2026
pulisher
Sep 04, 2026

Perspective Therapeutics (CATX) backer trims stake but keeps 11.5M shares - Stock Titan

Sep 04, 2026
pulisher
Sep 04, 2026

10% owner of Perspective Therapeutics (NYSE: CATX) sells 113,914 shares over two days - Stock Titan

Sep 04, 2026
pulisher
Sep 04, 2026

Perspective Therapeutics (CATX) backer Lantheus now owns 10% after share sales - Stock Titan

Sep 04, 2026
pulisher
Sep 03, 2026

Perspective Therapeutics Inc (CATX) Insider Sell: 10% Owner Holdings, Lantheus Disposes of 35,769 Shares - GuruFocus

Sep 03, 2026
pulisher
Sep 03, 2026

Perspective Therapeutics (CATX) holder sells 35K shares, still owns 11.6M - Stock Titan

Sep 03, 2026
pulisher
Sep 02, 2026

Perspective Therapeutics Inc (CATX) Insider Sell: 10% Owner Holdings, Lantheus Disposes of 78,145 Shares - GuruFocus

Sep 02, 2026
pulisher
Sep 02, 2026

Lantheus Holdings sells $245,609 in Perspective Therapeutics stock By Investing.com - Investing.com Nigeria

Sep 02, 2026
pulisher
Sep 02, 2026

Lantheus Holdings sells $245,609 in Perspective Therapeutics stock - Investing.com

Sep 02, 2026
pulisher
Sep 01, 2026

Technical Reactions to LNTH Trends in Macro Strategies - Stock Traders Daily

Sep 01, 2026
pulisher
Aug 31, 2026

Lantheus Holdings, Inc. (LNTH): Analyst Consensus and Growth Potential Amid Healthcare Innovations - DirectorsTalk Interviews

Aug 31, 2026
pulisher
Aug 29, 2026

LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lanth - The National Law Review

Aug 29, 2026
pulisher
Aug 29, 2026

Lantheus Holdings 1Q Net $118.4M >LNTH - Moomoo

Aug 29, 2026
pulisher
Aug 29, 2026

LNTH Stock Alert: Halper Sadeh LLC is Investigating Whether Lantheus Holdings, Inc. is Obtaining a Fair Price for its Shareholders - The Daily Tribune News

Aug 29, 2026
pulisher
Aug 24, 2026

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Exploring a 7% Upside Potential in the Healthcare Sector - DirectorsTalk Interviews

Aug 24, 2026
pulisher
Aug 20, 2026

Healthcare Equipment and Supplies Stocks Q2 Recap: Benchmarking Lantheus (NASDAQ:LNTH) - Yahoo Finance

Aug 20, 2026
pulisher
Aug 19, 2026

Lantheus (LNTH) EPS and Revenue: Profit Per Share Surpasses Its Benchmark in Latest Trading; Session Move - Vinanet

Aug 19, 2026
pulisher
Aug 19, 2026

Lantheus Holdings CAO Kimberly Brown Sells 463 Shares for Tax Withholding Purposes - Kalkine Media

Aug 19, 2026
pulisher
Aug 19, 2026

Lantheus Holdings, Inc. Stock 12‑Month Price Target Cut to $106.3, Implies 6% Upside - TradingView

Aug 19, 2026
pulisher
Aug 18, 2026

Lantheus (LNTH) Q2 2026 Filing Snapshot: The EPS Result Is Above Expectation in the Current Update; Market Follow-Through: The Stock Records a 0.64% Decrease on the DayInvestor Earnings Call - Vinanet

Aug 18, 2026
pulisher
Aug 17, 2026

Lantheus Wins FDA Approval for Alzheimer's Tau PET Imaging Agent - finance.biggo.com

Aug 17, 2026
pulisher
Aug 17, 2026

B.Riley downgrades Lantheus stock rating on Curium acquisition By Investing.com - Investing.com Australia

Aug 17, 2026
pulisher
Aug 17, 2026

B.Riley downgrades Lantheus stock rating on Curium acquisition - Investing.com Nigeria

Aug 17, 2026
pulisher
Aug 17, 2026

FDA approves Lantheus tau PET imaging agent for Alzheimer’s disease - DOTmed

Aug 17, 2026
pulisher
Aug 17, 2026

Lantheus Holdings, Inc. (LNTH) Stock Analysis: A Healthcare Powerhouse with 6.21% Potential Upside - DirectorsTalk Interviews

Aug 17, 2026
pulisher
Aug 17, 2026

Tauklarify PET approval for Lantheus in AD NFT pathology - pharmaphorum

Aug 17, 2026
pulisher
Aug 15, 2026

FDA Approves Lantheus Imaging Drug for Alzheimer's Diagnostics - Sahm

Aug 15, 2026
pulisher
Aug 15, 2026

What Does Lantheus Holdings (LNTH) FDA Approval Mean For Its Alzheimer’s Push? - webull.com

Aug 15, 2026
pulisher
Aug 15, 2026

Weekly Buzz: LNTH, CBLL Win FDA Nod; AURA Cuts Jobs; TDY Buys VREX; CGEM, DFTX Meet Trial Goals - RTTNews

Aug 15, 2026
pulisher
Aug 14, 2026

US FDA approves Lantheus’ brain-imaging agent for Alzheimer’s assessment - KWSN

Aug 14, 2026
pulisher
Aug 14, 2026

LNTH Looks 10.1% Overvalued on GF Value™ - GuruFocus

Aug 14, 2026
pulisher
Aug 14, 2026

US FDA approves Lantheus' brain-imaging agent for Alzheimer's assessment - Reuters

Aug 14, 2026
pulisher
Aug 14, 2026

Lantheus Wins FDA Approval for Alzheimer's Tau Imaging Agent Tauklarify - marketscreener.com

Aug 14, 2026
pulisher
Aug 14, 2026

Lantheus gains FDA nod for tau PET imaging agent in Alzheimer’s - Seeking Alpha

Aug 14, 2026
pulisher
Aug 14, 2026

FDA approves Lantheus’ tau imaging agent for Alzheimer’s disease - Investing.com

Aug 14, 2026

Lantheus Holdings Inc Azioni (LNTH) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$46.11
price up icon 1.56%
RDY RDY
$11.71
price down icon 1.43%
$22.86
price down icon 2.93%
$156.57
price up icon 0.92%
$16.38
price down icon 0.73%
$503.86
price down icon 0.58%
Capitalizzazione:     |  Volume (24 ore):